Research identifies a gene that may be linked to focal cortical dysplasia, a common cause of drug-resistant epilepsy. New research has identified changes (mutations) in a gene called FOXJ3 that may be ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results